Subscribe to Press Releases

X
Subscribe

Immunotherapies for Life

Scientific Collaboration

Working with Leading Research Institutions

Ymabs has partnered with the leading medical and research organization, Memorial Sloan Kettering Cancer Center, to advance a pipeline of novel immunotherapies. Memorial Sloan Kettering is one of 41 National Cancer Institute-designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment. The close collaboration between physicians and scientists enables Memorial Sloan Kettering to provide patients with the best care available as they work to discover more-effective strategies to prevent, control, and ultimately cure cancer. Memorial Sloan Kettering’s education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan Kettering has an impact on cancer treatment and biomedical research around the world.